CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
21 hedge funds and large institutions have $1.64M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
21
Holding in Top 10
–
Calls
$310K
Puts
–
Top Buyers
| 1 | +$143K | |
| 2 | +$23.1K | |
| 3 | +$1.07K | |
| 4 |
CS
Clear Street
New York
|
+$428 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11 |
Top Sellers
| 1 | -$262K | |
| 2 | -$85.7K | |
| 3 | -$46.2K | |
| 4 |
ICM
Ionic Capital Management
New York
|
-$35.1K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$31.6K |